XENE - Company ID 0001582313
As of 2026-09-08, Xenon Pharmaceuticals Inc. (XENE) has a market capitalization of $5.78 B, making it the #1315 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-08 | $5.78 B |
| 2026-09-07 | $5.78 B |
| 2026-09-06 | $5.78 B |
| 2026-09-05 | $5.78 B |
| 2026-09-04 | $5.78 B |
| 2026-09-03 | $5.82 B |
| 2026-09-02 | $5.82 B |
| 2026-09-01 | $5.80 B |
| 2026-08-31 | $5.82 B |
| 2026-08-30 | $5.80 B |
| 2026-08-29 | $5.80 B |
| 2026-08-28 | $5.78 B |
As of 2026-09-08, Xenon Pharmaceuticals Inc. (XENE) has a market capitalization of $5.78 B, making it the #1315 most valuable US-listed company.
Xenon Pharmaceuticals Inc. is the #1315 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-27 | $5.99 B |
| 2026-08-26 | $6.17 B |
| 2026-08-25 | $5.83 B |
| 2026-08-24 | $5.85 B |
| 2026-08-23 | $5.87 B |
| 2026-08-22 | $5.87 B |
| 2026-08-21 | $5.87 B |
| 2026-08-20 | $5.77 B |
| 2026-08-19 | $6.02 B |
| 2026-08-18 | $6.09 B |
| 2026-08-17 | $6.03 B |
| 2026-08-16 | $6.03 B |
| 2026-08-15 | $6.03 B |
| 2026-08-14 | $6.01 B |
| 2026-08-13 | $6.21 B |
| 2026-08-12 | $6.31 B |
| 2026-08-11 | $6.11 B |
| 2026-08-10 | $6.17 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.